Biosimilar market size forecast Japan 2011-2020
Projected market size of the biosimilars industry in Japan from 2011 to 2020 (in billion Japanese yen)
The statistic depicts the projected market size of the biosimilars industry in Japan from 2015 to 2020. In 2020, the Japanese biosimilars market was forecasted to reach approximately 43.5 billion Japanese yen, up from around 9.8 billion yen in 2015.
Projected market size of the biosimilars industry in Japan from 2011 to 2020 (in billion Japanese yen)
Source
More information
Statistics on "Pharmaceutical industry in Japan "
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Celltrion sales revenue South Korea 2013-2017
- Celltrion R&D investment South Korea 2013-2017
- Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Peak sales per new pharmaceutical asset 2010-2018
- Pharma revenue share forecast worldwide for 2060, by country
- Sold packaging units of phytopharmaceuticals in Germany in 2017, by sales channel
- Pharma revenue share worldwide 2017, by country
- Pharmaceutical expenditure forecast worldwide by country 2030
- Members of EFPIA's pharmaceutical market value 1990-2017
- Italy: net result of pharmaceutical companies 2015-2017
- Sales of homeopathics and herbal remedies in Germany from 2015 to 2017
- Average prices of non-prescription drugs in Germany in 2015
- Italy: value added of pharmaceutical companies 2015-2017
- Leading indication groups of phytopharmaceuticals based on revenue in Germany 2017
- Value share of generic pharmaceuticals in Finland 2007-2015
- Import value of vaccines to Qatar 2013-2015
- Value of pharmaceutical sales in Slovenia 2007-2016
- Import value of vaccines to MENA 2011-2015
- Value of royalties for major minerals in Odisha, India 2012-2015
Statistics on "Pharmaceutical industry in Japan "
Related topics
About Statista
